Cargando…

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B

BACKGROUND/AIMS: Renal toxicity is a concern in patients with chronic hepatitis B taking nucleotide analogues, such as adefovir (ADV) and tenofovir disoproxil fumarate (TDF). We sought to determine the long-term renal effects of nucleotide analogue treatment versus entecavir (ETV) treatment. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Young Youn, Chang, Young, Nam, Joon Yeul, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Yoon Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096224/ https://www.ncbi.nlm.nih.gov/pubmed/31060115 http://dx.doi.org/10.5009/gnl18474

Ejemplares similares

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
por: Cho, Eun Ju, et al.
Publicado: (2015)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2018)

Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2019)

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
por: Cho, Eun Ju, et al.
Publicado: (2018)

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
por: Lee, Minjong, et al.
Publicado: (2018)

Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
por: Kim, Dong Hyun, et al.
Publicado: (2017)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

FLOWERING LOCUS T has higher protein mobility than TWIN SISTER OF FT
por: Jin, Suhyun, et al.
Publicado: (2015)

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study
por: Jun, Dae Won, et al.
Publicado: (2013)

Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
por: Kim, Jihye, et al.
Publicado: (2023)

A Granulomatous Drug Eruption Induced by Entecavir
por: Yoon, Jimi, et al.
Publicado: (2013)

Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis
por: Yu, Su Jong, et al.
Publicado: (2016)

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
por: Ze, EunYoung, et al.
Publicado: (2014)

Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog
por: Jiang, Lei, et al.
Publicado: (2016)

Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
por: Choe, Won Hyeok, et al.
Publicado: (2019)

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK
por: Lee, Seulki, et al.
Publicado: (2018)

The Impact of COVID-19 Protocols on the Continuity of Care for Patients with Hypertension
por: Lee, Seo Yoon, et al.
Publicado: (2022)

Higher Long-Term Mortality in Patients with Non-ST-Elevation Myocardial Infarction than ST-Elevation Myocardial Infarction after Discharge
por: Han, Xiongyi, et al.
Publicado: (2021)

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
por: Chung, Goh Eun, et al.
Publicado: (2017)

Finding and Characterizing Mammary Analogue Secretory Carcinoma of the Salivary Gland
por: Jung, Min Jung, et al.
Publicado: (2013)

Ethanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase
por: Jin, Young-Hee, et al.
Publicado: (2017)

Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
por: Yoo, Jeong-Ju, et al.
Publicado: (2018)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
por: Woo, Hyun Young, et al.
Publicado: (2020)

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study
por: Kim, Hwi Young, et al.
Publicado: (2018)

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
por: Hwang, Joo An, et al.
Publicado: (2015)

Occupational radiation exposure in femoral artery approach is higher than radial artery approach during coronary angiography or percutaneous coronary intervention
por: Kim, Jung-Su, et al.
Publicado: (2020)

Entecavir-associated thrombocytopenia
por: Yu, Yi, et al.
Publicado: (2021)

Successful resuscitation of refractory ventricular fibrillation with double sequence defibrillation
por: Park, SungJoon, et al.
Publicado: (2021)

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
por: Park, Jung Gil, et al.
Publicado: (2015)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
por: Ahn, Sang Hoon, et al.
Publicado: (2013)

Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine
por: Yasutake, Yoshiaki, et al.
Publicado: (2020)

Nutrition education discouraging sugar intake results in higher nutrient density in diets of pre-school children
por: Yeom, Ma-Young, et al.
Publicado: (2019)

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
por: Jwa, Hye Young, et al.
Publicado: (2016)

An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
por: Hong, Sung-Jun, et al.
Publicado: (2020)

Exertional Desaturation Has Higher Mortality Than Non-Desaturation in COPD
por: Liu, Shih-Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u07j8nnjfoqucadmbbk9pg1197